Spring Health vs Eli Lilly

Side-by-side comparison of AI visibility scores, market position, and capabilities

Eli Lilly leads in AI visibility (81 vs 59)
Spring Health logo

Spring Health

ChallengerHealthcare Tech

Mental Health Benefits & AI Care Matching

AI mental health benefits platform. $3.3B valuation. 50M+ lives. Raised $460M+. Acquiring Alma (Jan 2026). Founded 2016, NYC. Potential IPO candidate 2026. Private.

AI VisibilityBeta
Overall Score
C59
Category Rank
#135 of 596
AI Consensus
77%
Trend
stable
Per Platform
ChatGPT
56
Perplexity
59
Gemini
54

About

Spring Health is a global mental health technology company founded in 2016 by CEO April Koh and President Adam Chekroud, headquartered in New York City. Raised over $460M including a $100M Series E (July 2024) led by Generation Investment Management at $3.3B valuation. April Koh became the youngest woman to lead a multibillion-dollar startup at 29.

Full profile
Eli Lilly logo

Eli Lilly

LeaderHealthcare

General

Indianapolis global pharma (NYSE: LLY) at $45B 2024 revenue (+32%); first healthcare company to $1T market cap (Nov 2024) with Mounjaro/Zepbound tirzepatide (37% revenue) and oral GLP-1 orforglipron Phase 3 competing with Novo Nordisk.

AI VisibilityBeta
Overall Score
A81
Category Rank
#17 of 596
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
80
Perplexity
75
Gemini
77

About

Eli Lilly and Company is an Indianapolis, Indiana-based global pharmaceutical company — publicly traded on the New York Stock Exchange (NYSE: LLY) as an S&P 500 Dow Jones Industrial Average component — that in November 2024 became the world's most valuable pharmaceutical company with a historic $1 trillion market capitalization, the first healthcare company ever to reach this milestone. In fiscal year 2024, Lilly achieved approximately $45 billion in revenue, representing 32% growth from 2023, driven by blockbuster GLP-1 medications tirzepatide (Mounjaro for type 2 diabetes and Zepbound for obesity and obstructive sleep apnea), which together accounted for 37% of 2024 revenues. Other key products include Trulicity (dulaglutide, 12% of revenue), Humalog (insulin lispro, 5%), and Kisunla (donanemab), the first new Alzheimer's therapy approved for early symptomatic disease in 2024. An oral GLP-1 pill (orforglipron) is in Phase 3 clinical trials. CEO David Ricks has led the company since 2017. Founded in 1876 by Colonel Eli Lilly in Indianapolis, the company pioneered mass production of Jonas Salk's polio vaccine in 1955 and was among the first to produce human insulin using recombinant DNA technology.

Full profile

AI Visibility Head-to-Head

59
Overall Score
81
#135
Category Rank
#17
77
AI Consensus
71
stable
Trend
stable
56
ChatGPT
80
59
Perplexity
75
54
Gemini
77
62
Claude
86
63
Grok
85

Key Details

Category
Mental Health Benefits & AI Care Matching
General
Tier
Challenger
Leader
Entity Type
platform
company

Capabilities & Ecosystem

Capabilities

Only Spring Health
Mental Health Benefits & AI Care Matching

Integrations

Only Spring Health
Spring Health is classified as platform. Eli Lilly is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.